An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Biologic License Application (BLA): 125141
Company: GENZYME

Products on BLA 125141

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
MYOZYME	ALGLUCOSIDASE ALFA	20MG/KG	INJECTABLE; IV (INFUSION)	Prescription	None	No	No

Approval Date(s) and History, Letters, Labels, Reviews for BLA 125141

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
04/28/2006	ORIG-1	Approval		N/A; Orphan	Label (PDF) Letter (PDF) Review		https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/125141LBLini.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/125141s0_LTR.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2006/125141s000_MyozymeTOC.html

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
02/18/2020	SUPPL-223	Supplement	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125141s223lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/125141Orig1s223,125291Orig1s151ltr.pdf
05/30/2019	SUPPL-222	Supplement	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125141s222lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/125141Orig1s222, 125291Orig1s148ltr.pdf
05/20/2014	SUPPL-219	Supplement	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125141s219lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/125141Orig1s219ltr.pdf
07/09/2012	SUPPL-176	Supplement	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/125141s0176lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/125141Orig1s0176ltr.pdf
06/11/2010	SUPPL-116	Supplement		Label is not available on this site.
12/08/2008	SUPPL-74	Supplement	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/125141_74lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/125141s074ltr.pdf

Labels for BLA 125141

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
02/18/2020	SUPPL-223	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125141s223lbl.pdf
05/30/2019	SUPPL-222	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125141s222lbl.pdf
05/20/2014	SUPPL-219	Labeling	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125141s219lbl.pdf
07/09/2012	SUPPL-176	Labeling	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/125141s0176lbl.pdf
12/08/2008	SUPPL-74	Labeling	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/125141_74lbl.pdf
04/28/2006	ORIG-1	Approval	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/125141LBLini.pdf

Top